Tianwei Wang Selected Research

nisin Z

4/2022

Nisin Z attenuates lipopolysaccharide-induced mastitis by inhibiting the ERK1/2 and p38 mitogen-activated protein kinase signaling pathways.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tianwei Wang Research Topics

Disease

7	Neoplasms (Cancer) 04/2022 - 01/2017
5	Glioma (Gliomas) 05/2021 - 03/2018
3	Fibrosis (Cirrhosis) 10/2019 - 01/2019
2	Glioblastoma (Glioblastoma Multiforme) 12/2021 - 03/2018
2	Infections 01/2021 - 01/2019
2	Acute Kidney Injury (Acute Renal Failure) 10/2019 - 01/2019
2	Ischemia 10/2019 - 01/2019
1	Non-Muscle Invasive Bladder Neoplasms 05/2022
1	Carcinoma (Carcinomatosis) 04/2022
1	Mastitis 04/2022
1	Bovine Mastitis 04/2022
1	Necrosis 10/2019
1	Reperfusion Injury 10/2019
1	Ureteral Obstruction 01/2019
1	Inflammation (Inflammations) 01/2019
1	Chronic Renal Insufficiency 01/2019
1	Diarrhea 01/2019
1	Atrophy 01/2019
1	Ruptured Aneurysm 03/2018
1	Atherosclerosis 01/2017

Drug/Important Bio-Agent (IBA)

2	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 05/2021 - 01/2021
1	Epirubicin (Ellence)FDA LinkGeneric 05/2022
1	pirarubicinIBA 05/2022
1	Gemcitabine FDA Link 05/2022
1	Biomarkers (Surrogate Marker)IBA 04/2022
1	B7-H1 AntigenIBA 04/2022
1	nisin ZIBA 04/2022
1	p38 Mitogen-Activated Protein KinasesIBA 04/2022
1	LipopolysaccharidesIBA 04/2022
1	AntioxidantsIBA 01/2022
1	Circular RNAIBA 12/2021
1	Glial Fibrillary Acidic ProteinIBA 05/2021
1	Telomerase (Telomerase Reverse Transcriptase)IBA 05/2021
1	Bacteriocins (Lantibiotics)IBA 01/2021
1	asparaginylendopeptidase (legumain)IBA 10/2020
1	Polylactic Acid-Polyglycolic Acid CopolymerIBA 10/2019
1	oltiprazIBA 10/2019
1	CollagenIBA 10/2019
1	Temozolomide (Temodar)FDA LinkGeneric 07/2019
1	Therapeutic UsesIBA 01/2019
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	CytokinesIBA 01/2019
1	Extracellular Matrix ProteinsIBA 01/2019
1	astaxanthine (astaxanthin)IBA 01/2019
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2019
1	DNA (Deoxyribonucleic Acid)IBA 01/2017
1	MethyltransferasesIBA 01/2017

Therapy/Procedure

3	Radiotherapy 06/2018 - 03/2018
2	Drug Therapy (Chemotherapy) 05/2022 - 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Therapeutics 07/2019
1	Adjuvant Radiotherapy 07/2019
1	Oral Administration 01/2019